Saic Venture Capital Corp
—- Market cap
- —
- Debt
- —
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $136.49B · View financials
Decision snapshot: Saic Venture Capital Corp stock price vs BMY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BMY's multiple
Needs EPS (TTM), BMY P/E.
Implied fair value · at Saic Venture Capital Corp's multiple
Needs Saic Venture Capital Corp P/E.
Engine logicSaic Venture Capital Corpvalued onBMY’smultiple
Metric by metric
Snapshot Sep 4, 4:00 PM ET
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: Saic Venture Capital Corp Latest annual filing · BMY FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 74% equity / 26% debt · EV / Revenue 3.60x · EV / EBITDA 11.15x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
SAIC VENTURE CAPITAL CORP · implied price per share
Reporting currency could not be verified.
BRISTOL-MYERS SQUIBB COMPANY · implied price per share
Bear
$59.11
Base
$72.93
Bull
$92.88
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Saic Venture Capital Corp · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
—
2.55x
Net debt / EBITDA
Leverage against operating earnings
—
2.37x
Cash and equivalents
Liquid reserves on the balance sheet
—
$10.21B
Total debt
Interest-bearing obligations outstanding
—
$47.09B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Pfizer Inc.
Saic Venture Capital Corp vs PFE
Merck & Co., Inc.
Saic Venture Capital Corp vs MRK
AbbVie Inc.
Saic Venture Capital Corp vs ABBV
Eli Lilly and Company
Saic Venture Capital Corp vs LLY
Amgen Inc.
Saic Venture Capital Corp vs AMGN
Gilead Sciences, Inc.
Saic Venture Capital Corp vs GILD
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.